Selling part of your liver is illegal in the United States and in nearly every other country on Earth. The National Organ Transplant Act of 1984 (NOTA) makes it a federal crime to buy or sell human organs, punishable by up to five years in prison and a $50,000 fine. You can, however, voluntarily donate a portion of your liver to someone who needs a transplant, and that process involves a surprisingly complex intersection of surgery, law, ethics, and money that goes well beyond a simple yes-or-no answer.
How the Ban Came About
The story of NOTA starts with a Virginia physician named H. Barry Jacobs, who in 1983 publicly announced plans to create a brokerage matching people willing to sell their kidneys with patients who needed transplants. The proposal caused an immediate uproar. Congressman Albert Gore Jr. introduced a bill to prohibit organ sales and establish a National Center for Organ Transplantation to coordinate procurement agencies into a network.1PubMed. Bill introduced to thwart kidney brokerage The bill passed with broad bipartisan support and became NOTA. Although Jacobs’s scheme involved kidneys, the law covers all solid organs, including the liver.
NOTA does not just apply to back-alley deals. It criminalizes any exchange of “valuable consideration” for an organ, which courts have interpreted broadly. The law carves out specific exceptions for expenses directly related to donation, such as travel, lodging, and lost wages, but the organ itself cannot carry a price tag. Similar laws exist across Europe, Asia, and most of the rest of the world.
What Living Liver Donation Actually Looks Like
Living donor liver transplantation is a real and increasingly common procedure. A healthy adult can donate a portion of their liver, typically the right lobe (about 60% of the organ), to a patient with end-stage liver disease or acute liver failure. The donor’s remaining liver regenerates over the following months, and the transplanted portion grows inside the recipient as well.
The evaluation process before you even get to the operating room is intense. Transplant programs require a psychosocial evaluation to confirm that the donor’s decision is voluntary, free of coercion, guilt, or financial enticement, and that the donor has adequate emotional and financial support for recovery.2American Journal of Transplantation. Psychosocial Evaluation of Living Unrelated Kidney Donors: Consensus Statement An independent donor advocate, separate from the recipient’s medical team, represents the donor’s interests throughout. If there is any hint that money is changing hands beyond approved reimbursement, the transplant center is obligated to stop the process.
The Difference Between Reimbursement and Payment
This is where the legal terrain gets genuinely tricky, and where many donors feel caught in a gap. NOTA prohibits selling an organ, but it explicitly allows reimbursement for reasonable expenses tied to donation. In practice, that means a donor can receive money for travel to the transplant center, lodging during evaluation and recovery, and lost wages. The recipient’s insurance or the transplant program typically covers the donor’s medical costs. Some federal programs, like the National Living Donor Assistance Center, exist specifically to help cover non-medical expenses.
The concept that transplant policy experts aim for is called “financial neutrality,” meaning that donating an organ should leave you neither richer nor poorer than you were before.3PubMed. Financial Neutrality for Living Organ Donors: Reasoning, Rationale, Definitions, and Implementation Strategies The idea is to cover all medical, travel, lodging, and wage costs so that no one is deterred from donating by the financial hit, while also ensuring that no one donates because they see it as a payday.4PubMed. Living and deceased organ donation should be financially neutral acts
In reality, financial neutrality remains an aspiration rather than an achievement. A prospective study following living liver donors found that the majority reported out-of-pocket medical and non-medical expenses, and 44% described those costs as burdensome. Donors with lower incomes were hit harder, and those in non-professional jobs before donation were more likely to suffer adverse financial outcomes.5PubMed Central. Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2) Recovery from liver donation typically takes several weeks to a few months, and many donors face gaps in wage coverage that existing programs do not fully close.
Insurance and Employment Protections After Donation
One of the less obvious concerns for potential donors is what happens to their insurance and job security after the surgery. The Affordable Care Act prohibits health insurers from denying coverage or charging higher premiums based on preexisting conditions, which includes having donated part of your liver.6American Journal of Transplantation. Financial toxicity in living donor liver transplantation: A call to action for financial neutrality But state-level protections vary considerably, and life insurance and disability insurance are not covered by the same rules. Some donors have reported difficulty obtaining or affording life insurance policies after donation.
On the employment side, there is no uniform federal law guaranteeing job protection specifically for organ donors. Some states have passed their own laws granting donors paid or unpaid leave, but coverage is patchy. Policy experts have recommended standardized legislation to offer employment and insurability protections, along with dedicated reimbursement systems for lost wages and incidental costs.7PubMed Central. Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation–Recommendations from a Consensus Conference Until those recommendations become law, donors navigate an inconsistent patchwork of protections.
The Medical Risks of Donating Part of Your Liver
Liver donation is major abdominal surgery, and the risks are real. In a large study tracking 393 donors, about 38% experienced at least one complication. Most were minor, but roughly a quarter had complications rated as potentially life-threatening, about 2% had life-threatening events, and three donors (0.8%) died.8PubMed Central. Donor Morbidity After Living Donation for Liver Transplantation A broader analysis of living liver donor deaths in the United States found that death within the first year after donation occurred in roughly 1 in 1,000 donors.9American Journal of Transplantation. Characterization of Living Liver Donor Deaths in the United States
Beyond the immediate surgical risks, longer-term health comparisons are less reassuring than many donors are led to expect. A large Korean study comparing living liver donors with matched healthy controls found that donors had a higher rate of all-cause mortality compared to healthy adults who had never donated, along with higher rates of liver failure, depression, and several other conditions.10PubMed. Outcomes of living liver donors are worse than those of matched healthy controls Depression and lower income were identified as risk factors for higher mortality in the donor group. The overall mortality rate remained low in absolute terms, but the comparison to matched controls makes the point that donation is not risk-free, even years after surgery.
How the Liver Regenerates
The liver’s ability to regrow is what makes living donation possible in the first place. After a right-lobe donation, the donor’s remnant liver (about 40-45% of the original volume) grows rapidly. In one study, the remnant reached about 69% of the original total liver volume at one month and roughly 90% by six months.11PubMed. Liver regeneration in donors and adult recipients after living donor liver transplantation Another study found that at three months, donor remnants had reconstituted to about 80% of the starting total liver volume, though only about 6% of donors reached 100% by that point.12PubMed Central. Liver regeneration after living donor transplant
Most of the regrowth happens in the first few months, then tapers. Donors’ livers regenerate fastest when the donated portion was larger, because the stimulus to regenerate is stronger when the remnant is smaller. On the recipient’s side, the transplanted lobe also grows, and in some studies actually reaches the expected standard liver volume faster than the donor’s remnant.13PubMed Central. Comparison of liver regeneration between donors and recipients after adult right lobe living-donor liver transplantation Regeneration is real and robust, but the regrown liver is not a perfect replica of the original. Some donors report persistent physical symptoms long after the volume has recovered.
Physical and Psychological Aftereffects
Studies consistently show that well over half of living liver donors, and in some surveys up to 75%, report ongoing symptoms they connect to the donation experience. The most common are gastrointestinal problems like heartburn, nausea, and food intolerances; general abdominal discomfort and muscle weakness that limits daily activity; and pain or hernias at the incision site.14PubMed Central. Long-Term Medical and Psychosocial Outcomes in Living Liver Donors These issues often improve over time, but for a meaningful fraction of donors they linger for years.
Psychologically, the picture is more nuanced. A large prospective study found that rates of major depression, alcohol misuse, and anxiety disorders among living liver donors were low in the first two years, in the range of 0-5% depending on the condition and the time point. Many donors reported a sense of personal growth and meaning from the experience.15PubMed Central. Psychological Outcomes of Living Liver Donors from a Multi-Center, Prospective Study: Results from the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL) The major psychological risk factor was the recipient’s outcome: donors whose recipients died were more likely to experience guilt, a sense of responsibility, and emotional distress. Close psychosocial monitoring for those donors is now considered essential.
The Black Market and Transplant Tourism
The fact that legal organ sales are banned almost everywhere has not eliminated commercial organ transactions. Estimates suggest that commercial transplants make up about 5% of all organ transplants globally, and the illegal organ trade generates somewhere between $600 million and $1.2 billion in profit per year.16PubMed Central. Ending the organ trade: an ethical assessment of regulatory possibilities Most of the documented black-market activity involves kidneys rather than livers, because kidney removal is a simpler surgery and donors can live normally with one kidney. Liver lobe sales are rarer but not unheard of, particularly in parts of South and Southeast Asia.
The outcomes for people who buy or sell organs through these channels are considerably worse than in legitimate transplant programs. Transplant tourism is associated with high rates of surgical complications, organ rejection, and serious infections, including HIV, hepatitis B and C, tuberculosis, and a long list of fungal and parasitic diseases.17PubMed Central. Paid Organ Donation: Case Report and Review of the Literature on Health Implications for Kidney Donors and Recipients 18PubMed Central. Key issues in transplant tourism Sellers are typically from extremely poor and vulnerable populations, and international bodies have condemned organ commercialism for decades on the grounds that it exploits those who can least afford the health consequences.19PubMed Central. The Declaration of Istanbul on Organ Trafficking and Transplant Tourism
The Ethical Debate Over Regulated Markets
Not everyone agrees that a blanket ban on organ sales is the right approach. Some ethicists and transplant researchers argue that a carefully regulated market could increase organ supply, reduce black-market exploitation, and respect the autonomy of adults who freely choose to sell. The counterargument has several layers. One concern is “commodification,” the idea that putting a price on human body parts fundamentally changes how we view persons and bodies in ways that damage human dignity.20PubMed. Commodification arguments for the legal prohibition of organ sale
A more practical objection draws on what has actually happened where organ selling has been tolerated, particularly in parts of India. Studies of those markets found that selling a kidney did not meaningfully improve the seller’s long-term financial situation, undermining the main argument that sellers are making a rational decision about their own best interests.21Journal of Medical Ethics. A legal market in organs: the problem of exploitation Sellers tended to spend the payment quickly, often on existing debts, and reported persistent health problems and social stigma that left them worse off than before.
On the other side, some researchers have proposed that a system of regulated incentives, carefully designed to protect donors and provide clear benefit to both parties, could function ethically if properly controlled. Such a system would need to allow competent, informed adults to make their own decisions about their bodies while preventing the exploitation that has characterized unregulated markets.22PubMed Central. Incentives for Organ Donation: Proposed Standards for an Internationally Acceptable System No country has implemented such a system for solid organs, and the political appetite for doing so remains extremely low.
Non-Monetary Incentives and Creative Workarounds
Some countries have experimented with incentives that fall short of direct payment. Israel’s 2008 Organ Transplant Law is the most notable example. It grants priority on the organ transplant waiting list to people who have either registered as organ donors for at least three years, consented to the donation of a deceased relative’s organs, or previously been living organ donors themselves.23American Journal of Transplantation. A New Era of Organ Transplantation in Israel The system rewards willingness to participate in the transplant ecosystem without paying anyone cash. It was a response to Israel’s particularly wide gap between organ need and availability.24PubMed Central. Israel’s 2008 Organ Transplant Law: continued ethical challenges to the priority points model
Another mechanism that sidesteps the payment question entirely is paired exchange. In kidney transplantation, paired exchange programs have been common for years: if your intended recipient is incompatible with your organ but compatible with another donor’s recipient, the pairs swap. Paired liver exchanges are newer and more complicated because liver donation is a bigger surgery and the logistics are harder to coordinate. Programs have also proposed “voucher” systems where a person donates now and receives a voucher guaranteeing a future transplant to a designated family member if one is ever needed.25PubMed Central. Evolving swaps in transplantation: global exchange, vouchers, liver, and trans-organ paired exchange Non-directed altruistic donors can also initiate chains where their single donation triggers a cascade of transplants across multiple incompatible pairs.26Journal of Hepatology. Paired exchange living donor liver transplantation: Indications, stumbling blocks, and future considerations
Technologies That Could Change the Equation
The entire organ-sales debate is shaped by scarcity. If livers were not in short supply, there would be far less reason to consider paying for them. Researchers are pursuing two main approaches to breaking the scarcity bottleneck. Xenotransplantation, the transplantation of organs from genetically modified animals (typically pigs) into humans, has made significant strides in recent years. Gene-editing technologies have been used to remove porcine retroviruses and reduce the immune rejection that historically made pig-to-human transplants fail quickly.27PubMed Central. LIVER TRANSPLANTATION: WILL XENOTRANSPLANTATION BE THE ANSWER TO THE DONOR ORGAN SHORTAGE? The critical shortage of liver transplant donors has made xenotransplantation a particularly active area of research.28PubMed Central. Revolutionizing medicine: Exploring the breakthroughs in liver xenotransplantation
Bioengineered organs represent an even more ambitious goal: growing a transplantable liver from a patient’s own cells, eliminating both the donor shortage and the need for immunosuppressive drugs. Both xenotransplantation and bioengineering remain experimental, but advances in each field are expected to inform the other, potentially yielding hybrid approaches like bioengineered pig organs.29PubMed. Current progress in xenotransplantation and organ bioengineering Neither is ready for routine clinical use, but both represent plausible paths toward a future in which the question of selling liver tissue becomes less urgent simply because the supply problem has been solved from a different direction.